Efficacy of LY333328 against Experimental Methicillin-Resistant Staphylococcus aureus Endocarditis

The in vivo efficacy of LY333328, a new glycopeptide antibiotic, was compared with that of vancomycin by using the rabbit model of left-sided methicillin-resistant Staphylococcus aureus endocarditis. Animals received LY333328 or vancomycin (25 mg/kg of body weight every 24 or 8 h, respectively) for...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Kaatz, Glenn W., Seo, Susan M., Aeschlimann, Jeffrey R., Houlihan, Heather H., Mercier, Renee-Claude, Rybak, Michael J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105587/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9559828/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.4.981
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!